Ardelyx Inc (ARDX)
7.815
+0.02
(+0.32%)
USD |
NASDAQ |
May 17, 16:00
7.815
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Max Drawdown (5Y): 95.33% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.33% |
March 31, 2024 | 95.33% |
February 29, 2024 | 95.33% |
January 31, 2024 | 95.33% |
December 31, 2023 | 95.33% |
November 30, 2023 | 95.33% |
October 31, 2023 | 95.33% |
September 30, 2023 | 95.33% |
August 31, 2023 | 95.33% |
July 31, 2023 | 95.33% |
June 30, 2023 | 95.33% |
May 31, 2023 | 95.33% |
April 30, 2023 | 95.33% |
March 31, 2023 | 95.33% |
February 28, 2023 | 95.33% |
January 31, 2023 | 95.33% |
December 31, 2022 | 95.33% |
November 30, 2022 | 95.33% |
October 31, 2022 | 95.33% |
September 30, 2022 | 95.33% |
August 31, 2022 | 95.33% |
July 31, 2022 | 95.33% |
June 30, 2022 | 95.33% |
May 31, 2022 | 95.33% |
April 30, 2022 | 95.33% |
Date | Value |
---|---|
March 31, 2022 | 95.33% |
February 28, 2022 | 95.33% |
January 31, 2022 | 94.95% |
December 31, 2021 | 94.95% |
November 30, 2021 | 94.95% |
October 31, 2021 | 94.95% |
September 30, 2021 | 94.95% |
August 31, 2021 | 94.95% |
July 31, 2021 | 94.95% |
June 30, 2021 | 94.95% |
May 31, 2021 | 94.95% |
April 30, 2021 | 94.95% |
March 31, 2021 | 94.95% |
February 28, 2021 | 94.95% |
January 31, 2021 | 94.95% |
December 31, 2020 | 94.95% |
November 30, 2020 | 94.95% |
October 31, 2020 | 94.95% |
September 30, 2020 | 94.95% |
August 31, 2020 | 94.95% |
July 31, 2020 | 94.95% |
June 30, 2020 | 94.95% |
May 31, 2020 | 94.95% |
April 30, 2020 | 94.95% |
March 31, 2020 | 94.95% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.95%
Minimum
May 2019
95.33%
Maximum
Feb 2022
95.12%
Average
94.95%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Nektar Therapeutics | 99.30% |
Rigel Pharmaceuticals Inc | 86.40% |
Vistagen Therapeutics Inc | 98.38% |
Adverum Biotechnologies Inc | 97.89% |
SeaStar Medical Holding Corp | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 1.748 |
Beta (5Y) | 0.8694 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.93% |
Historical Sharpe Ratio (5Y) | 0.1192 |
Historical Sortino (5Y) | 0.2128 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.88% |